Literature DB >> 7952121

Determination of ketorolac enantiomers in plasma using enantioselective liquid chromatography on an alpha 1-acid glycoprotein chiral stationary phase and ultraviolet detection.

M H Mills1, L E Mather, X S Gu, J L Huang.   

Abstract

A chirally selective high-performance liquid chromatographic assay was developed to measure the R(+) and S(-) enantiomers of ketorolac in plasma for pharmacokinetic studies. Naproxen sodium [S(+) enantiomer] (10 micrograms) was used as an internal standard. Plasma samples (0.5 ml) were acidified (50 microliters of 4 M H3PO4 to pH 1.5), extracted into 0.4 ml of 10% pentan-2-ol in hexane and back-extracted into 0.15 ml of base (20 mM NaOH pH to 7-8), of which samples (5 microliters) were chromatographed on a 100 x 4 mm I.D. column packed with an HPLC chiral stationary phase based upon immobilized alpha 1-acid glycoprotein (Chiral AGP-CSP) with 4% propan-2-ol in 0.1 M NaH2PO4 pH 5.5, at 0.9 ml/min. Detection was at 325 nm and run time was 10 min. Retention times of R- and S-ketorolac and of S(+)-naproxen were 3.3, 4.8 and 6.4 min, respectively. The metabolite p-hydroxyketorolac was not resolved enantiomerically and had a retention time of 2.2 min. The assay was linear over the range 0.5-10 mg/l, with precisions < 5% C.V. Good separations (alpha > 1.35) and resolutions (Rs > 3.23) between peaks were achieved. The sensitivity could be extended to 35 micrograms/l with less precision by increasing the injection volume to 100 microliters.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7952121     DOI: 10.1016/0378-4347(94)00228-2

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  5 in total

Review 1.  Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.

Authors:  J C Gillis; R N Brogden
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

Review 2.  Characterization of drug interactions with serum proteins by using high-performance affinity chromatography.

Authors:  David S Hage; Jeanethe Anguizola; Omar Barnaby; Abby Jackson; Michelle J Yoo; Efthimia Papastavros; Erika Pfaunmiller; Matt Sobansky; Zenghan Tong
Journal:  Curr Drug Metab       Date:  2011-05       Impact factor: 3.731

Review 3.  Characterization of drug-protein interactions in blood using high-performance affinity chromatography.

Authors:  David S Hage; Abby Jackson; Matthew R Sobansky; John E Schiel; Michelle J Yoo; K S Joseph
Journal:  J Sep Sci       Date:  2009-03       Impact factor: 3.645

4.  Validated Stability-indicating Reverse-phase Ultra-performance Liquid Chromatography Method for Simultaneous Determination of Sodium Methylparaben, Sodium Propylparaben and Ketorolac Tromethamine in Topical Dosage Forms.

Authors:  C Roy; J Chakrabarty; P B Modi
Journal:  Indian J Pharm Sci       Date:  2013-03       Impact factor: 0.975

5.  New chiral reverse phase HPLC method for enantioselective analysis of ketorolac using chiral AGP column.

Authors:  Sunil K Dubey; Jangala Hemanth; Chiranjeevi Venkatesh K; R N Saha; S Pasha
Journal:  J Pharm Anal       Date:  2012-07-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.